Enhanced Cross-Reactive and Polyfunctional Effector-Memory T Cell Responses by ICVAX—a Human PD1-Based Bivalent HIV-1 Gag-p41 Mosaic DNA Vaccine

Author:

Chen Samantha M. Y.1,Wong Yik Chun1,Yim Lok Yan1,Zhang Haoji2,Wang Hui3,Lui Grace Chung Yan4,Li Xin12,Tang Xian3,Cheng Lin3,Du Yanhua1,Peng Qiaoli13,Wang Jinlin1,Kwok Hau-yee1,Huang Haode1,Lau Thomas Tsz-Kan1,Chan Denise Pui Chung5,Wong Bonnie Chun Kwan4,Liu Li1ORCID,Chakrabarti Lisa A.67,Lee Shui Shan5,Chen Zhiwei13ORCID

Affiliation:

1. AIDS Institute, Department of Microbiology, State Key Laboratory of Emerging Infectious Diseases, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, People’s Republic of China

2. Department of Veterinary Medicine, Foshan University, Foshan, People’s Republic of China

3. HKU-AIDS Institute Shenzhen Research Laboratory and AIDS Clinical Research Laboratory, Guangdong Key Laboratory of Emerging Infectious Diseases, Shenzhen Key Laboratory of Infection and Immunity, Shenzhen Third People’s Hospital, Shenzhen, People’s Republic of China

4. Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong

5. Stanley Ho Centre for Emerging Infectious Diseases, Postgraduate Education Centre, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong

6. Control of Chronic Viral Infection Group, Virus and Immunity Unit, Institut Pasteur, Paris, France

7. Centre National de la Recherche Scientifique, UMR 3569, Paris, France

Abstract

This study presents that ICVAX, a PD1-based DNA vaccine against HIV-1, could induce broad and polyfunctional T cell responses against different HIV-1 subtypes. ICVAX encodes a recombinant antigen consisting of the human soluble PD1 domain fused with two mosaic Gag-p41 antigens.

Funder

Mega-Projects of National Science Research for the 13th Five-Year Plan in China

FHB | Health and Medical Research Fund

HKU | University of Hong Kong

HKU | Li Ka Shing Faculty of Medicine, University of Hong Kong

University-Industry Collaboration Programme, Innovation and Technology Commission, the Government of Hong Kong Special Administration Region of the People's Republic of China

Theme-based Research Scheme, Hong Kong Research Grant Council

French National Research Agency (Agency Nationale de la Recherche)/RGC Joint Research Scheme, Hong Kong Research Grant Council

General Research Fund, Hong Kong Research Grant Council

Collaborative Research Fund, Hong Kong Research Grant Council

Shenzhen Science and Technology Innovation Commission | Sanming Project of Medicine in Shenzhen

Publisher

American Society for Microbiology

Subject

Virology,Insect Science,Immunology,Microbiology

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3